Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification-Reference-Cited by-同舟云学术

Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification

Published:2019-04-19 Issue:4 Volume:14 Page:e0215582
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Matzkin Haim,Chen Juza,Agai Rubi,Ziv-Baran Tomer,Mabjeesh Nicola J.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography;HH Holm;J Urol,1983

2. Patient Reported Outcomes of NRG Oncology/RTOG 0232: A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone in Intermediate Risk Prostate Cancer;DW Bruner;Abstr Present Annu Meet Am Soc Radiat Oncol (ASTRO) San Antonio,2018

3. Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation;T Ohashi;Radiother Oncol,2013

4. A dose-response study for I-125 prostate implants;RG Stock;Int J Radiat Oncol Biol Phys,1998

5. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant;RG Stock;Tech Urol,2000

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose-rate brachytherapy as monotherapy versus as boost in unfavorable intermediate-risk localized prostate cancer: A matched-pair analysis;Brachytherapy;2023-09

2. Hyperoside alleviates toxicity of β-amyloid via endoplasmic reticulum-mitochondrial calcium signal transduction cascade in APP/PS1 double transgenic Alzheimer's disease mice;Redox Biology;2023-05

3. Virtual HDR Boost for Prostate Cancer: Rebooting a Classic Treatment Using Modern Tech;Cancers;2023-03-28

4. Prostate specif c antigen density as a prognostic factor in patients with prostate cancer treated with combined hormonal radiation therapy;Siberian journal of oncology;2022-06-28

5. Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer;Strahlentherapie und Onkologie;2021-08-05